Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 4/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.51 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.46 |
| ▸ | DRD4 | P21917 | 8/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1551985 | 0.91 | EPHA2 (0.47) | EPHA2ERBB2EPHB4PDE4BNR1H4 | |
| SCHEMBL1552682 | 0.89 | EPHA2 (0.50) | EPHA2ERBB2EPHB4PDE4BNR1H4 | |
| SCHEMBL1552680 | 0.89 | EPHA2 (0.50) | EPHA2ERBB2EPHB4PDE4BNR1H4 | |
| SCHEMBL1552605 | 0.89 | EPHA2 (0.46) | EPHA2ERBB2EPHB4PDE4BNR1H4 | |
| SCHEMBL1551943 | 0.89 | EPHA2 (0.46) | EPHA2ERBB2EPHB4PDE4BNR1H4 | |
| SCHEMBL1552522 | 0.88 | EPHA2 (0.47) | EPHA2ERBB2EPHB4PDE4BDRD4 | |
| SCHEMBL27715197 | 0.88 | EPHA2 (0.47) | EPHA2ERBB2EPHB4PDE4BDRD4 | |
| SCHEMBL1551919 | 0.88 | EPHA2 (0.44) | EPHA2ERBB2EPHB4 | |
| SCHEMBL1552945 | 0.88 | EPHA2 (0.44) | EPHA2ERBB2EPHB4 | |
| SCHEMBL31076483 | 0.88 | EPHA2 (0.44) | EPHA2ERBB2EPHB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642778-A1 | LSD1 MODULATORS | Recursion Pharmaceuticals, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024141757-A1 | LSD1 MODULATORS | EXSCIENTIA AI LIMITED (GB) | 2024-07-04 | — | — | WO | disclosed |